Wells Fargo’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Wells Fargo’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-49,068	Closed	-$4.94M	–	6653
2014 Q4	$4.94M	Sell	49,068 -20,907	-30%	-$1.63M	﹤0.01%	2353
2014 Q3	$4.64M	Sell	69,975 -4,838	-6%	-$318K	﹤0.01%	2374
2014 Q2	$5.22M	Sell	74,813 -23,490	-24%	-$1.6M	﹤0.01%	2296
2014 Q1	$7.19M	Sell	98,303 -540,042	-85%	-$40.3M	﹤0.01%	2061
2013 Q4	$44M	Sell	638,345 -765,298	-55%	-$49.5M	0.02%	811
2013 Q3	$89.2M	Sell	1,403,643 -643,782	-31%	-$38.9M	0.04%	456
2013 Q2	$98.9M	Buy	+2,047,425	New	+$101M	0.05%	400

Wells Fargo's CBST Position: Q1 2015 in Review

Wells Fargo sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 49,068 shares — an estimated $4.94M sold.

Wells Fargo first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $98.9M in Q2 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

Wells Fargo reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Wells Fargo sold 49,068 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $4.94M.
Wells Fargo first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
Wells Fargo's CUBIST PHARMACEUTICALS INC position peaked at $98.9M in Q2 2013.
0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Wells Fargo's 13F filing for Q1 2015, filed 12 May 2015.